Hardide selected for Airbus A380 wing components
14 May 2019
("Hardide" or "the Group" or "the Company")
Hardide-A coating to be used for Airbus A380 wing components
Hardide (AIM: HDD), the developer and provider of advanced surface coating technology, is pleased to announce that its Hardide-A coating has been selected as the replacement for hard chrome plating (HCP) on Airbus A380 compression flap pads.
Hardide-A has been developed specifically to meet the needs of the aerospace industry; it is a hard wearing, quality product, environmentally compliant with demonstrable long-term performance qualities.
Robert Goddard, Non-Executive Chairman
Philip Kirkham, CEO
Jackie Robinson, Communications Manager
Tel: +44 (0) 1869 353 830
Graham Herring / Heather Armstrong / Florence Chandler
Tel: +44 (0) 2039 346 630
Henrik Persson / Kate Bannatyne / Matthew Radley
Tel: +44 (0) 2072 200 500
Notes to editors:
Hardide develops, manufactures and applies advanced technology tungsten-carbide coatings to a wide range of engineering components. Its patented technology is unique in combining in one material, a mix of toughness and resistance to abrasion, erosion and corrosion; together with the ability to coat accurately interior surfaces and complex geometries. The material is proven to offer dramatic improvements in component life, particularly when applied to components that operate in very aggressive environments. This results in cost savings through reduced downtime and increased operational efficiency. Customers include leading companies operating in oil and gas exploration and production, valve and pump manufacturing, precision engineering and aerospace industries.
The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.